Epigenetic modulation of autophagy pathway by small molecules in colorectal cancer: a systematic review
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05982-1 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Mozhdeh Zamani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Antineoplastic Agents, Autophagy, Colorectal Neoplasms, Epigenesis, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
PURPOSE: Colorectal cancer (CRC) remains a global health challenge with limited treatment success due to drug resistance. Recent research highlights the potential of small molecules to modulate CRC by targeting epigenetics or autophagy pathways. This systematic review explores the epigenetic effect of small molecules on autophagy in CRC, aiming to identify novel therapeutic strategies. METHODS: Following PRISMA guidelines, we systematically reviewed 508 studies from PubMed, Scopus, and Web of Science databases until August 13, 2023. RESULTS: Eight studies met inclusion criteria, examining the role of small molecules as epigenetic modulators (Histone acetylation/deacetylation, DNA methylation/demethylation and gene expression regulation by miRNAs) influencing the autophagy pathway in CRC. The studies encompassed in vitro and animal model in vivo studies. Small molecules exhibited diverse effects on autophagy in CRC. For instance, panobinostat promoted autophagy leading to CRC cell death, while aspirin inhibited autophagy flux, reducing aspirin-mediated CRC cell death. The epigenetic modulation of autophagy by various small molecules differently affects their anticancer effect, which underscores the complexity of therapeutic interventions. CONCLUSION: Understanding the intricate dynamics among small molecules, epigenetic modifications, and autophagy in CRC is crucial for developing targeted therapeutic strategies. Considering the dual role of autophagy in tumorigenesis and tumor suppression, administration of these small molecules may differently affect the cancer cell fate and drug response or resistance based on their effect on the autophagy pathway. Therefore, recognition of the epigenetics mechanism of anticancer small molecules on autophagy may contribute to deciding how to prescribe them for better CRC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. suny.respina@gmail.com.
- Autophagy Research Center, Department of Biochemistry, Shiraz University of Medical Sciences, Shiraz, Iran. mokaram2@gmail.com.
Zitieren
APA
Zamani, M., Safari, F., Siri, M., Igder, S., Khatami, N., Dastghaib, S., & Mokarram, P. (2024). Epigenetic modulation of autophagy pathway by small molecules in colorectal cancer: a systematic review. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05982-1
Vancouver
Zamani M, Safari F, Siri M, Igder S, Khatami N, Dastghaib S, et al. Epigenetic modulation of autophagy pathway by small molecules in colorectal cancer: a systematic review. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05982-1
BibTeX
@article{Zamani2024,
author = {Zamani, Mozhdeh and Safari, Farima and Siri, Morvarid and Igder, Somayeh and Khatami, Niloofar and Dastghaib, Sanaz and Mokarram, Pooneh},
title = {Epigenetic modulation of autophagy pathway by small molecules in colorectal cancer: a systematic review},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05982-1}
}
EUVIMED